Opiant Pharmaceuticals, Inc. Reports Fiscal First Quarter 2018 Financial Results
Dec 04, 2017 21:05 pm UTC| Business
SANTA MONICA, Calif., Dec. 04, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.095 per Share
Dec 04, 2017 21:05 pm UTC| Business
NEW YORK, Dec. 04, 2017 -- PennantPark Floating Rate Capital Ltd. (the "Company") (NASDAQ:PFLT) (TASE:PFLT) declares monthly distribution for December 2017 of $0.095 per share, payable on January 2, 2018 to stockholders...
SMART Global Holdings Announces Closing of Secondary Offering of Ordinary Shares
Dec 04, 2017 21:05 pm UTC| Business
NEWARK, Calif., Dec. 04, 2017 -- SMART Global Holdings, Inc. (“SMART”) (NASDAQ:SGH), parent company of SMART Modular Technologies, Inc., today announced the closing of an underwritten public offering of 3,261,102 of its...
Dec 04, 2017 21:05 pm UTC| Business
TUSTIN, Calif., Dec. 04, 2017 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics manufacturing services to...
P10 Industries, Inc. announces it changed its name
Dec 04, 2017 21:05 pm UTC| Business
DALLAS, Dec. 04, 2017 -- P10 Industries, Inc. (OTC:PIOE) has announced that it has changed its name. More details can be found at www.p10holdings.com under the What’s New section of the Investor Relations page. ...
Connecture Announces Brian Lindstrom as New Chief Financial Officer
Dec 04, 2017 21:05 pm UTC| Business
BROOKFIELD, Wis., Dec. 04, 2017 -- Connecture, Inc. (OTCQX:CNXR), a provider of web-based information systems used to create health insurance marketplaces, today announced that Brian Lindstrom will join their team as...
TRACON Pharmaceuticals Announces Appointment of Brian Daniels, M.D., to Scientific Advisory Board
Dec 04, 2017 21:05 pm UTC| Business
SAN DIEGO, Dec. 04, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...
FxWirePro- Major Economic Events for the day